2 TP53 Mutations Worsen Blood Cancer Severity, Says Study
source: pixabay.com

2 TP53 Mutations Worsen Blood Cancer Severity, Says Study

Recently, the MDS Foundation announced that two TP53 gene mutations result in worse patient outcomes in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). According to their international and multi center study,…

Continue Reading 2 TP53 Mutations Worsen Blood Cancer Severity, Says Study
Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
https://pixabay.com/photos/swing-playground-children-playing-1188132/

Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida

Dayton Abbott is like many kindergarteners; she loves to tell jokes, play games, and hang out with friends during recess. But her playground at Alexander Elementary School wasn't built for…

Continue Reading Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
Onureg Approved for Continuous AML Treatment
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

Onureg Approved for Continuous AML Treatment

Earlier this week, the FDA approved oral azacitidine (Onureg) for patients with acute myeloid leukemia (AML). According to the ASCO Post, Onureg continuously treats adult patients who previously achieved remission.…

Continue Reading Onureg Approved for Continuous AML Treatment
CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay.com

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19

Business Insider recently interviewed Marissa Oliver, a resident of New York City, who told us about the problems she has encountered during her recovery from COVID-19. Marissa, an arts manager,…

Continue Reading Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19